Overweight and obese patients’ attitudes towards anti-obesity treatments, and attitude associated factors

Author:

Güven Alper Tuna1ORCID,Özdede Murat2ORCID,Kayaoğlu Beyazıt1ORCID,Şerifli Nermin1ORCID,Özçiçek Aslı1ORCID,Geleri Tuba Işıl1ORCID

Affiliation:

1. BASKENT UNIVERSITY, FACULTY OF MEDICINE

2. HACETTEPE UNIVERSITY, FACULTY OF MEDICINE

Abstract

Introduction: Obesity is a public health problem with a rising prevalence. When lifestyle modifications, diet, and exercise fail, anti-obesity medications and surgeries are treatment options. However, they seem to be underutilized, due in part to patients’ attitudes towards these modalities. This study aimed to investigate patients’ attitudes toward these treatments. Methodology: A descriptive survey was conducted in a face-to-face fashion. Weight perception, prior weight loss trials, exercise and dietary treatments, perceptions related to obesity and its treatment, and demographic factors, were assessed in relation to anti-obesity medications and surgical treatments. Perception was analyzed both verbally and visually. Misperception was defined as being thinner than reality misperceptions (TTRM), fatter than reality misperceptions (FTRM), or either of them (ETFTRM). Results: 198 participants completed the survey. 30.8% and 23.7% of the participants would consider anti-obesity medications and surgeries, respectively. Females were more likely to consider anti-obesity medications (43.9% vs. 21.6%, p = 0.001). Patients who had exercised to lose weight were more likely to consider anti-obesity surgery (28.9% vs. 16.7%, p = 0.04). Appropriate weight perception was 16.2%. Weight misperception was not associated with higher or lower rates of anti-obesity treatments. However, among the patients in the highest body mass index (BMI) group (BMI > 35), participants with pure-TTRM were more likely to consider anti-obesity medications (66.7% vs. 18.8%, p = 0.01). Discussion: Medical and surgical obesity treatments are considered at a low rate among candidates or at-risk patients. Age, gender, exercise history, and pure-TTRM were associated with higher treatment considerations.

Publisher

Sakarya Tip Dergisi

Reference26 articles.

1. 1. WHO. World Health Organization. Obesity. Available at https://www.who.int/news-room/fact-sheets/detail/obesity-and overweight#:~:text=Worldwide%20adult%20obesity%20has%20more,16%25%20were%20living%20with%20obesity. Accessed on March 17, 2024

2. 2. Türkiye İstatistik Kurumu (TÜİK). Türkiye Sağlık Araştırması 2022. 2022. Available at https://data.tuik.gov.tr/Bulten/Index?p=Turkiye-Saglik-Arastirmasi-2022-49747, Accessed on March 17, 2024

3. 3. Leitner DR, Frühbeck G, Yumuk V, Schindler K, Micic D, Woodward E, et al. Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way. Obes Facts. 2017;10(5):483–92.

4. 4. ElSayed NA, Aleppo G, Bannuru RR, Bruemmer D, Collins BS, Ekhlaspour L, et al. 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes–2024. Diabetes Care. 2024 Jan 1;47(Supplement_1):S145–57.

5. 5. Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, et al. European Guidelines for Obesity Management in Adults. Obes Facts. 2015;8(6):402–24.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3